Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys

https://doi.org/10.1016/0376-8716(93)90067-ZGet rights and content

Abstract

Rhesus monkeys (n = 6) were surgically prepared with double lumen i.v. catheters and the effects of continuous infusion of the monoamine reuptake blockers mazindol, sertraline and fluoxetine were examined on behavior maintained by food presentation or i.v. cocaine injections. Under baseline conditions, lever pressing was maintained under a three-component multiple schedule of reinforcement in which food (1-g banana-flavored pellets) was available for 600 s under a fixed-ratio 30 schedule in the first and third components. In the second component, the dose of cocaine that maintained maximum rates of responding (0.03 or 0.05 mg/kg per injection) was available for 1800 s under a fixed-ratio 30 schedule. There was a brief time-out after each reinforcer. When behavior was stable, mazindol (0.4–3.2 mg/kg per 24 h), sertraline (0.1–8.0 mg/kg per 24 h) or fluoxetine (0.4–3.2 mg/kg per 24 h) was administered continuously via the second lumen of the double lumen catheter. Mazindol was administered for the same number of sessions that were required for responding to decline to low levels when the monkeys were allowed to self-administer saline [5–13] while sertraline and fluoxetine were administered for a minimum of 21 days. Baseline conditions were reinstated between doses of each drug. Each drug decreased cocaine-maintained responding in a dose-related manner. In most cases, food-maintained responding was disrupted at doses equal to or lower than those that decreased cocainemaintained responding. Additionally, the higher doses of each drug decreased food intake outside the daily sessions. These results suggest that monoamine uptake blockers with prominent effects on either dopamine or serotonin neurotransmission can decrease cocaine self-administration but only at doses that also affect behavior maintained by other reinforcers.

References (45)

  • M.C. Wilson et al.

    Mazindol selfadministration in the rhesus monkey

    Pharmacol. Biochem. Behav.

    (1976)
  • J.H. Woods et al.

    Chlorpromazine and haloperidol-induced changes in some behavioral effects of cocaine and amphetamine

  • S.L. Batki et al.

    Fluoxetine for cocaine abuse in methadone patients: Preliminary findings

    NIDA Res. Monogr.

    (1991)
  • J. Bergman et al.

    Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys

    J. Pharmacol. Exp. Ther.

    (1989)
  • A.J. Bertalmio et al.

    Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis

    J Pharmacol. Exp. Ther.

    (1989)
  • A.W. Brotman et al.

    An open trial of maprotiline for the treatment of cocaine abuse: A pilot study

    J. Clin. Psychopharmacol.

    (1988)
  • M.E. Carroll et al.

    Intravenous cocaine self-administration in rats is reduced by dietary l-tryptophan

    Psychopharmacology (Berl.)

    (1990)
  • M.E. Carroll et al.

    A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior

    Psychopharmacology (Berl.)

    (1989)
  • R.C. Corwin et al.

    Anorectics: Effects on food intake and self-administration in rhesus monkeys

    Alcohol Drug Res.

    (1987)
  • K.A. Cunningham et al.

    Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat

    Psychopharmacology (Berl.)

    (1991)
  • I.A. Diakogiannis et al.

    Mazindol treatment of cocaine abuse. A double blind investigation

    NIDA Res. Monogr.

    (1991)
  • M.W. Fischman et al.

    Effects of desipramine maintenance on cocaine self-administration by humans

    J. Pharmacol. Exp. Ther.

    (1990)
  • Cited by (77)

    • Medications development for food-based and drug use disorders

      2019, Advances in Pharmacology
      Citation Excerpt :

      First, different approaches have been used to increase serotonergic activity. For example, preclinical studies with serotonin-selective reuptake inhibitors (SSRIs) have shown that increases in serotonergic activity can attenuate the rewarding or reinforcing effects of psychomotor stimulants such as amphetamine (Yu, Smith, Smith, & Lyness, 1986) and cocaine (Howell & Byrd, 1995; Kleven & Woolverton, 1993). However, effective doses of SSRIs tend to be relatively high, which leads to undesirable nonspecific behavioral effects that limit the clinical value of this approach.

    • Mirtazapine attenuates cocaine seeking in rats

      2017, Journal of Psychiatric Research
      Citation Excerpt :

      These results were consistent with those in previous reports where rats trained to self-administer food and then exposed to multiple extinction sessions showed a decrease in lever press responses (Aoyama et al., 2014; Krasnova et al., 2014). Other authors indicate that antidepressants do not change motivation for food (Kleven and Woolverton, 1993). This is in line with the results of this study, namely that animals previously trained to self-administer food and then dosed with mirtazapine during extinction had lever press responses similar to those in the FOOD + Vehicle group.

    • The effect of CA1 dopaminergic system in harmaline-induced amnesia

      2015, Neuroscience
      Citation Excerpt :

      The β-carboline alkaloids indicate modest affinity to 5-HT, dopamine and benzodiazepine receptors (Glennon et al., 2000). These alkaloids influence central neurotransmitters such as dopamine (Moura et al., 2006; Nasehi et al., 2010, 2012), via inhibition of monoamine reuptake systems (Kleven and Woolverton, 1993; Baum et al., 1996; Yang et al., 2011), and inhibition MAO-A or B (Glennon et al., 2000; Touiki et al., 2005). Some evidences displayed that harmaline change the extracellular and tissue level of dopamine (Kim et al., 1970; Glick et al., 1994, 1996).

    • Monoamine transporter inhibitors and substrates as treatments for stimulant abuse

      2014, Advances in Pharmacology
      Citation Excerpt :

      Preclinical studies have clearly indicated that serotonin plays an important role in the behavioral effects of cocaine. Acute administration of SERT inhibitors attenuates the behavioral-stimulant effects of cocaine in squirrel monkeys (Howell & Byrd, 1995; Howell, Czoty, & Byrd, 1997) and decreases cocaine self-administration in rodents (Carroll, Lac, Asencio, & Kragh, 1990) and nonhuman primates (Czoty, Ginsburg, & Howell, 2002; Kleven & Woolverton, 1993). The SERT inhibitor alaproclate also attenuated cocaine-induced increases in extracellular dopamine in squirrel monkeys (Czoty et al., 2002) and cocaine-induced activation of prefrontal cortex in rhesus monkeys (Howell et al., 2002).

    • Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: An in vivo microdialysis study

      2010, Pharmacological Reports
      Citation Excerpt :

      Second, what could be the mechanism responsible for this effect of 1MeTIQ? The behavioral effect of acute cocaine is closely related to the increase in dopamine concentration in the synaptic cleft associated with dopamine transporter (DAT) inhibition [34, 46, 70, 82] and the activation of dopamine D1 [86] and D2 receptors [17, 26, 28, 67]. In humans, a significant correlation has been observed between DAT occupancy and the intensity of the subjective effects produced by intravenous cocaine [79]; dopamine antagonists attenuate the behavioral effects of cocaine [16, 32, 83].

    View all citing articles on Scopus
    View full text